SCHEMBL30682020

SCHEMBL30682020

Cc1c(C(=O)O)c(Cl)nc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.60
KMT2A Q03164 3/20 0.57
HTT P42858 2/20 0.55
TSHR P16473 1/20 0.55
DHODH Q02127 9/20 0.53
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 2/20 0.49
MAPK1 P28482 1/20 0.47
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533563 1.00 PDE10A (0.60) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL8545852 0.86 PDE10A (0.70) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL10265349 0.82 PDE10A (0.74) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL2313999 0.82 MAOA (0.55) PDE10AKMT2ATSHRDHODHKDM4E
SCHEMBL7248226 0.82 KDM4E (0.70) KMT2AHTTKDM4EALDH1A1SMN1; SMN2
SCHEMBL26617556 0.81 PDE10A (0.62) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL27446591 0.81 DHODH (0.54) PDE10AKMT2ATSHRDHODHKDM4E
SCHEMBL1264633 0.81 PDE10A (0.62) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL27855178 0.79 PDE10A (0.60) PDE10AKMT2AHTTTSHRDHODH
SCHEMBL26617708 0.78 SMN1; SMN2 (0.58) KMT2AHTTTSHRDHODHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514789-A1 <SUP2/>? <SUB2/>?V?BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA1.8 FOR THE TREATMENT OF PAIN SiteOne Therapeutics, Inc. (US) 2025-03-05 EP disclosed
WO-2023211990-A1 BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA V1.8 FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2023-11-02 WO disclosed